Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22.9K Hold
9,479
﹤0.01% 1599
2025
Q4
$41.3K Sell
9,479
-692
-7% -$3.74K ﹤0.01% 1422
2025
Q3
$42.7K Hold
10,171
﹤0.01% 1460
2025
Q2
$29.2K Hold
10,171
﹤0.01% 1586
2025
Q1
$27.5K Hold
10,171
﹤0.01% 1568
2024
Q4
$24K Buy
10,171
+267
+3% +$710 ﹤0.01% 1557
2024
Q3
$19.3K Hold
9,904
﹤0.01% 1957
2024
Q2
$63.7K Hold
9,904
﹤0.01% 1155
2024
Q1
$63.7K Buy
9,904
+667
+7% +$6.06K ﹤0.01% 840
2023
Q4
$226K Buy
+9,237
New +$146K ﹤0.01% 415

Other funds holding GNLX

Blue Trust Inc's GNLX Position: Q1 2026 in Review

Blue Trust Inc held its Genelux (GNLX) position steady in Q1 2026 at 9,479 shares worth $22.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1599.

Blue Trust Inc first reported a position in GNLX in Q4 2023 and has held it in 10 quarters since. The position peaked at $226K in Q4 2023. 71 funds tracked by Wall St. Rank hold GNLX as of Q1 2026.

  • Blue Trust Inc held 9,479 shares of Genelux worth $22.9K as of Q1 2026.
  • Blue Trust Inc left its Genelux share count unchanged in Q1 2026.
  • Genelux made up ﹤0.01% of Blue Trust Inc's portfolio in Q1 2026, its #1599 holding.
  • Blue Trust Inc first reported a position in Genelux in Q4 2023 and has held it in 10 quarters since.
  • Blue Trust Inc's Genelux position peaked at $226K in Q4 2023.
  • 71 funds tracked by Wall St. Rank held Genelux as of Q1 2026.

Based on Blue Trust Inc's 13F filing for Q1 2026, filed 20 Apr 2026.